CVS Health Corp (CVS) Shares Bought by Greenleaf Trust

Greenleaf Trust grew its position in shares of CVS Health Corp (NYSE:CVS) by 25.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,786 shares of the pharmacy operator’s stock after purchasing an additional 3,569 shares during the period. Greenleaf Trust’s holdings in CVS Health were worth $1,165,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. Vanguard Group Inc. increased its holdings in CVS Health by 1.7% during the 3rd quarter. Vanguard Group Inc. now owns 84,873,814 shares of the pharmacy operator’s stock valued at $6,681,267,000 after purchasing an additional 1,445,887 shares during the period. Vanguard Group Inc increased its holdings in CVS Health by 1.7% during the 3rd quarter. Vanguard Group Inc now owns 84,873,814 shares of the pharmacy operator’s stock valued at $6,681,267,000 after purchasing an additional 1,445,887 shares during the period. BlackRock Inc. increased its holdings in CVS Health by 2.8% during the 3rd quarter. BlackRock Inc. now owns 76,197,017 shares of the pharmacy operator’s stock valued at $5,998,231,000 after purchasing an additional 2,061,915 shares during the period. FMR LLC increased its holdings in CVS Health by 4.3% during the 3rd quarter. FMR LLC now owns 30,069,260 shares of the pharmacy operator’s stock valued at $2,367,052,000 after purchasing an additional 1,250,473 shares during the period. Finally, Oregon Public Employees Retirement Fund increased its holdings in CVS Health by 6,858.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 25,089,377 shares of the pharmacy operator’s stock valued at $383,000 after purchasing an additional 24,728,818 shares during the period. 84.55% of the stock is owned by hedge funds and other institutional investors.

CVS stock opened at $55.60 on Friday. CVS Health Corp has a fifty-two week low of $51.93 and a fifty-two week high of $82.15. The company has a current ratio of 1.03, a quick ratio of 0.65 and a debt-to-equity ratio of 1.22. The company has a market cap of $70.89 billion, a price-to-earnings ratio of 7.85, a PEG ratio of 1.06 and a beta of 0.95.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 20th. The pharmacy operator reported $2.14 earnings per share for the quarter, topping analysts’ consensus estimates of $2.07 by $0.07. CVS Health had a positive return on equity of 17.49% and a negative net margin of 0.31%. The firm had revenue of $54.42 billion for the quarter, compared to the consensus estimate of $53.78 billion. During the same quarter in the prior year, the business earned $1.92 EPS. The business’s revenue for the quarter was up 12.5% on a year-over-year basis. On average, analysts expect that CVS Health Corp will post 6.8 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, May 3rd. Shareholders of record on Tuesday, April 23rd will be issued a dividend of $0.50 per share. The ex-dividend date is Monday, April 22nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.60%. CVS Health’s dividend payout ratio (DPR) is 28.25%.

A number of research analysts recently issued reports on the company. Barclays assumed coverage on CVS Health in a report on Tuesday, December 18th. They set an “overweight” rating and a $91.00 price target on the stock. UBS Group reduced their price target on CVS Health from $75.00 to $74.00 and set a “buy” rating on the stock in a report on Thursday, February 21st. Leerink Swann assumed coverage on CVS Health in a report on Tuesday, December 11th. They set an “outperform” rating on the stock. Goldman Sachs Group restated a “neutral” rating and set a $87.00 price target on shares of CVS Health in a report on Thursday, November 29th. Finally, Citigroup reduced their price target on CVS Health from $94.00 to $68.00 and set a “buy” rating on the stock in a report on Wednesday, March 6th. One analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have issued a buy rating to the company’s stock. CVS Health presently has an average rating of “Buy” and a consensus target price of $84.18.

In other CVS Health news, COO Jonathan C. Roberts sold 77,639 shares of the company’s stock in a transaction that occurred on Friday, February 1st. The stock was sold at an average price of $64.54, for a total transaction of $5,010,821.06. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Larry J. Merlo sold 166,368 shares of the company’s stock in a transaction that occurred on Tuesday, January 8th. The stock was sold at an average price of $69.04, for a total value of $11,486,046.72. Following the transaction, the insider now owns 496,577 shares in the company, valued at approximately $34,283,676.08. The disclosure for this sale can be found here. In the last quarter, insiders have acquired 23,600 shares of company stock worth $1,270,896 and have sold 412,039 shares worth $27,326,012. 0.53% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: This article was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2019/03/17/cvs-health-corp-cvs-shares-bought-by-greenleaf-trust.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Featured Story: Options Trading

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply